Lilly to Add Suicide Warning to Strattera – Medicaid May shrink $5.5 Billion spending on Schizophrenia Drug Thu, 29 Sep 2005 Reuters reports that Eli Lilly is adding a Black Box suicide warning to the Strattera label. Strattera has been promoted as a “non stimulant” treatment for ADHD. Since ADHD…
Evidence-based medicine? Overdosed America: The Broken Promise of American Medicine Thu, 17 Mar 2005 Dr. John Abramson is a physician who spent more than twenty years as a clinician treating patients in Appalachia and Massachusetts before writing “Overdosed America: The Broken Promise of American Medicine.” “When I first read of…
Petition FDA to Investigate if SSRI Induced School Shootings Fri, 25 Mar 2005 The Minnesota shooting rampage by 16-year old Jeff Weise, prompted the parent organization, Ablechild.org, to petition the FDA to conduct “a full investigation into the possible SSRI induced school shootings.” “It took 15 years for the FDA…
Additional information as of late Wed Oct 19: Although I was assured that attendance for a presentation by Dr. David Healy (at Columbia University School of Public Health on Oct. 20 at 12:30) would be open to the public, a problem seems to have emerged after an AHRP Infomail about…
Cash Interests Taint Drug Advice – NATURE / Death a Risk of Antipsychotics – AP Sun, 23 Oct 2005 An investigation by the journal, NATURE (the largest of its kind) reveals that not only do conflicts of interest taint the conduct and outcome of clinical trials, the authors who formulate…
More Spent on Psych Drugs for preschool kids than antibiotics or asthma – AP Mon, 17 May 2004 Data analysis by MEDCO, the nation’s largest prescription benefit manager found that between 2000–2003 there was a 49% increase in the use of psychotropic drugs for children and a 369% increase in…
NYU Students Drugged – NY Post Mon, 19 Apr 2004 Following three suicides by students at New York University (in Sept-October 2003), the University conducted an investigation of the NYU Student Counseling Services. The New York Post reports that an internal 116-page report (December 2003) reveals that whereas drugs were…
FDA Approves Lilly’s Cymbalta for Depression Despite Risk of Suicide Wed, 4 Aug 2004 In a display of arrogance and defiance–in the midst of federal investigations into the marketing of antidepressants–the FDA has approved Eli Lilly’s antidepression drug, Cymbalta (duloxetine). Lilly’s press release announced: “Cymbalta, a balanced and potent reuptake…
“Profits” / “Prophets”_NYT Editorial: Industry Distortion of the F.D.A. Wed, 8 Dec 2004 A White House transcript of President Bush’s speech at the Christmas tree lighting on Thursday: “We think of the patient hope of men and women across the centuries who listened to the words of the profits and…
Medicare Will cover New Treatments But Patients Will be Required to Enroll in Clinical Trials Fri, 5 Nov 2004 Dr. Mark McClellan, Director of Medicare, estimates that of Medicare’s $320 billion budget, “a third of all medical expenditures are for unnecessary or ill-advised treatments.” Medicare’s chief medical officer, Dr. Sean…
Spitzer’s Lawsuit Will Shake Up the Drug Industry – Full Disclosure is the Goal Thu, 3 Jun 2004 New York State Attorney General, Eliot Spitzer’s lawsuit against GlaxoSmithKline challenges the pharmaceutical industry’s fraudulent marketing of drugs. Karen Barth Menzes, an attorney representing victims of antidepressant drug effects, told The (So….
ACNP Summary Report Criticized as “Junk Science” Sun, 25 Jan 2004 related links: Reply to ACNP Report – Jonathan Leo, Ph.D. FDA Sham Conflicts of Interest Policy Most of the National press coverage of the controversy swirling around the claims and counter claims about drug suicidal obsessive thinking and behavior…
